Please login to the form below

Not currently logged in
Email:
Password:

Christian Schade joins Aprea AB

He takes up the role of president and chief executive officer

Aprea Christian SchadeSwedish biopharmaceutical firm Aprea AB has appointed Christian Schade as its president and chief executive officer.

Schade joins Aprea's Boston, Massachusetts office, bringing over 30 years of pharma and biotech industry experience, as well as corporate finance expertise, to his new role.

Most recently, Schade served as chief executive officer of Novira Therapeutics, which was acquired by Johnson & Johnson at the end of last year.

Prior to this, he worked at Omthera, a specialty dyslipidemia-focused pharmaceutical company, as executive vice president and chief financial officer during which time, Schade oversaw Omthera's sale to AstraZeneca.

Schade has also served as executive vice president and chief financial officer at Energy, and was senior vice president of administration and chief financial officer at Medarex where he led negotiations for the company's acquisition by Bristol-Myers Squibb.

Bernd Seizinger, chairman of Aprea's board of directors, said: “I am delighted to welcome Chris to Aprea.

“He is an accomplished biopharmaceutical executive with proven experience leading companies through times of change and growth.

“He will be an important asset to Aprea as we continue to develop novel anticancer therapies targeting the tumour suppressor protein, p53.

“Furthermore, Chris has excellent credentials to build a strategic leadership team in the US to complement the R&D activities of the team in Sweden.”

24th June 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Infographics